The standards contain information about both disk M02 and dilution M07 and M11 test procedures for aerobic and anaerobic bacteria. Your Alert Profile lists the documents that will be monitored. If the document is revised or amended, you will be notified by email. You may delete a document from your Alert Profile at any time. This standard is also available to be included in Standards Subscriptions.
|Published (Last):||11 February 2014|
|PDF File Size:||3.25 Mb|
|ePub File Size:||3.47 Mb|
|Price:||Free* [*Free Regsitration Required]|
The standards contain information about both disk M02 and dilution M07 and M11 test procedures for aerobic and anaerobic bacteria. Your Alert Profile lists the documents that will be monitored. If the document is revised or amended, you will be notified by email. You may delete a document from your Alert Profile at any time.
This standard is also available to be included in Standards Subscriptions. Standards Subscriptions from ANSI provides a money-saving, multi-user solution for accessing standards. Subscription pricing is determined by: the specific standard s or collections of standards, the number of locations accessing the standards, and the number of employees that need access. As the voice of the U. Available for Subscriptions. Add to Alert PDF. Please first log in with a verified email before subscribing to alerts.
Please first verify your email before subscribing to alerts. Already Subscribed to this document. You can download and open this file to your own computer but DRM prevents opening this file on another computer, including a networked server. PDF Price. Not a Member? This standard is not included in any packages.
We have no amendments or corrections for this standard. Request Proposal Price. Proceed to Checkout Continue Shopping. Useful Links.
Access Our Free Resources
MS23 includes a dosage regimen for imipenem for Pseudomonas aeruginosa and new information for detection of inducible clindamycin resistance using the D-zone test or broth microdilution for Streptococcus pneumoniae. Expanded recommendations for testing fluoroquinolones and salmonella, and elimination breakpoints for beta-lactamase, other than oxacillin cefoxitin , penicillin, and ceftaroline for staphylococci are included. Jean B. Work more efficiently by providing the latest recommendations for detecting emerging resistance in an easy-to-use format. There is a version specifically designed for pharmacists to enhance the implementation of M information tailored to their organization. The Clinical and Laboratory Standards Institute CLSI is a not-for-profit membership organization that brings together the varied perspectives and expertise of the worldwide laboratory community for the advancement of a common cause: to foster excellence in laboratory medicine by developing and implementing clinical laboratory standards and guidelines that help laboratories fulfill their responsibilities with efficiency, effectiveness, and global applicability. For additional information, visit the CLSI website at www.
Communications and Publications